New Delhi, Dec. 9 -- Pharma company Corona Remedies opened its initial public offering (IPO) for public subscription on Monday, December 8, with the issue scheduled to close on Wednesday, December 10.

The IPO carries a price band of Rs.1,008- Rs.1,062 per equity share. For retail participants, the minimum application size is one lot containing 14 shares, translating into a Rs.14,868 investment at the upper price limit. Applications can be submitted in multiples of 14 shares thereafter.

This Rs.655.37 crore public issue is structured entirely as an offer for sale (OFS) of 0.62 crore shares, with no fresh equity being issued. Existing shareholders - including Sepia Investments, Anchor Partners and Sage Investment Trust - are set to pare p...